How is ventilator-associated pneumonia (VAP) treated?

Updated: Apr 15, 2021
  • Author: Kartika Shetty, MD, FACP; Chief Editor: John L Brusch, MD, FACP  more...
  • Print


Empiric treatment of VAP should include coverage of S aureus, P aeruginosa, and other gram-negative bacilli.

MRSA should be covered empirically in patients with any of the following risk factors for antibiotic resistance:

  • Patients located in units where more than 10%-20% of S aureus isolates are MRSA
  • Patients in units where the prevalence of MRSA is unknown

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!